CRDMO for ADC drugs
Aktin Chemicals, Inc. offer comprehensive ADC drug R&D and manufacturing services (CRDMO) spanning early clinical stages to commercial manufacturing, supporting a wide range of conjugated drug modalities (XDCs), including antibody-drug conjugates (ADCs), peptide-drug conjugates (PDCs), and other innovative bioconjugates.
ADC CRDMO
|
Conjugate Drug Screening |
Preclinical | Phase I | Phase II | Phase III |
Commercial Manufacturing |
We specialize in the development of innovative payload-linker variants, offering custom synthesis services meticulously designed to fulfill each client’s specific specifications.
We provide flexible, scalable ADC conjugation solutions, including both site-specific and non-site-specific conjugation platforms.
We support quality research & analysis services for ADC development, covering structural elucidation, impurity analysis, microbiological control, and stability study.
